FDA Approves Pfizer RSV Vaccine for Older Adults

THURSDAY, June 1, 2023 -- Older adults have a second vaccine option for respiratory syncytial virus (RSV) following the U.S. Food and Drug Administration approval of a Pfizer vaccine on Wednesday.
The other shot for adults 60 years and older is made...